SymBio Pharmaceuticals Limited

Informe acción TSE:4582

Capitalización de mercado: JP¥10.7b

SymBio Pharmaceuticals Dirección

Dirección controles de criterios 1/4

SymBio Pharmaceuticals' CEO is Fuminori Yoshida, appointed in Mar 2005, has a tenure of 19.67 years. directly owns 2.57% of the company’s shares, worth ¥274.87M. The average tenure of the management team and the board of directors is 1.8 years and 3.7 years respectively.

Información clave

Fuminori Yoshida

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO19.7yrs
Participación del CEO2.6%
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

Sep 24
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely

SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Aug 06
SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up

Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Jun 11
Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge

Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

Feb 09
Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation

If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

Dec 18
If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%

CEO

Fuminori Yoshida (75 yo)

19.7yrs

Permanencia

Mr. Fuminori Yoshida serves as President, Chief Executive Officer and Chief Operating Officer of Takeda Bio Development Center Limited. Mr. Yoshida founded SymBio Pharmaceuticals Limited in March 2005 and...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Fuminori Yoshida
CEO, President19.7yrssin datos2.57%
¥ 274.9m
Takaaki Fukushima
Executive VP & Corporate Officerno datasin datossin datos
Koji Fukushima
Corporate Officer & Chief Medical Officerno datasin datossin datos
Yoshiharu Torikai
Corporate Officerno datasin datossin datos
Masahiko Okuno
Corporate Officer1.7yrssin datossin datos
Hiroyuki Horita
Corporate Officer1.8yrssin datossin datos

1.8yrs

Permanencia media

Equipo directivo experimentado: 4582's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Fuminori Yoshida
CEO, President19.7yrssin datos2.57%
¥ 274.9m
Robert Lewis
Member of Scientific Advisory Boardno datasin datossin datos
Tsutomu Takeuchi
Member of Scientific Advisory Boardno datasin datossin datos
Toshio Suda
Member of Scientific Advisory Boardno datasin datossin datos
Tatsutoshi Nakahata
Member of Scientific Advisory Boardno datasin datossin datos
Makoto Ogawa
Member of Scientific Advisory Boardno datasin datossin datos
Toshio Heike
Member of Scientific Advisory Boardno datasin datossin datos
Shigetoshi Matsumoto
Independent Outside Directorno datasin datos0.049%
¥ 5.2m
Shinji Nakao
Member of Scientific Advisory Boardno datasin datossin datos
Kiyoshi Watanabe
Outside Independent Director2.7yrssin datossin datos
Bruce David Cheson
Independent Outside Directorno datasin datossin datos
Eiji Ebinuma
Independent Outside Director3.7yrssin datossin datos

3.7yrs

Permanencia media

75yo

Promedio de edad

Junta con experiencia: 4582's board of directors are considered experienced (3.7 years average tenure).